Categories Earnings, Technology

Market bullish as Workday heads towards Q2 earnings

Workday (Nasdaq: WDAY) will report second-quarter 2020 financial results after the regular trading hours on Thursday, August 29. The market is quite bullish on the stock and expects higher earnings and revenues, driven by strong demand for its enterprise cloud applications.

The Pleasanton, California-based firm is expected to report $872.31 million in second-quarter revenues, up 30% year-over-year, primarily driven by strong subscription revenues.

In the first quarter, Workday’s subscription revenues grew 34%, to $701 million and accounted for 85% of its total revenues. For the second quarter, the management has projected another 32% growth in subscription revenues in the range of $746 to $748 million.

workday revenue trend

Analysts expect the human resource software provider to report earnings of $0.35 per share, four cents higher than a year ago. Notably, in all four trailing quarters, the company has surpassed earnings expectations.

During the first quarter, Workday reported adjusted earnings of $0.43 per share and revenue of $825 million that beat analysts estimates of $0.41 profit per share and $813.9 million in revenue. The company also raised its full-year outlook for subscription revenue to $3.045 to $3.060 billion, from the earlier projection of $3.030 billion to $3.045 billion.

READ: Things to know ahead of Nutanix Q4 earnings results

WDAY shares have gained 20% in the year-to-date period, compared to 23% growth achieved by the industry.

The stock has a 12-month average price target of $9.79, which is at a 22.8% upside from the last close. Earlier this month, two research firms, Mizohu and Compass Point, initiated coverage on the stock with Buy ratings.  

Mizuho said the company’s cloud and analytics platforms are game-changers that have the potential for $1 billion valuations.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top